The first batch of Russia’s Sputnik V vaccine for COVID-19 is likely to reach Kanpur’s Ganesh Shankar Vidyarthi Medical College by next week wherein the vaccine’s Phase 2 and Phase 3 human clinical trials will be conducted.
College principal R B Kamal, while speaking to PTI said the human clinical trials of the vaccine will start from next week. “As many as 180 volunteers have registered for the trials. Head of the research Saurabh Agarwal will determine the dosage of the vaccine to be administered. One dose will be administered and the condition of volunteers will be monitored to determine whether they need further doses or not,” he said.
Kamal told the volunteers’ vitals and condition will be checked periodically and the data will be analysed to determine whether the vaccine is a success or not.
The effect of the vaccine on the volunteers will be observed for seven months after the same is administered once, twice or thrice within an interval of 21 days. After observing the effects of the vaccine for a month, authorities will be apprised of the results of the trial and they will then make a decision accordingly.
